ARCH Venture Fund IX L.P. 13D and 13G filings for Lyell Immunopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:55 pm Purchase | 2024-12-31 | 13G | Lyell Immunopharma, Inc. LYEL | ARCH Venture Fund IX L.P. | 36,597,716 13.100% | 120,000 (+0.33%) | Filing |
| 2024-02-14 3:18 pm Purchase | 2023-12-31 | 13G | Lyell Immunopharma, Inc. LYEL | ARCH Venture Fund IX L.P. | 36,477,716 14.500% | 65,000 (+0.18%) | Filing |
| 2022-02-14 12:04 pm Purchase | 2021-12-31 | 13G | Lyell Immunopharma, Inc. LYEL | ARCH Venture Fund IX L.P. | 36,412,716 15.100% | 36,412,716 (New Position) | Filing |